Additionally, an analysis of PTC samples from The Cancer Genome Atlas (TCGA) revealed epigenetic silencing of KEAP1 through promoter hypermethylation, further linking KEAP1/NRF2 pathway dysregulation to thyroid carcinogenesis (50). This evidence concerns the gene NFE2L2 and thyroid gland disorder.